Now Available: Lithuania Pharmaceuticals & Healthcare Report Q3 2014
We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8 %, rising to a value of LTL2.1 1 bn ( USD 7 32 mn) in 2018. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market , albeit at the cost of increasing healthcare expenditure . Ceding control of monetary policy to Brussels leaves Lithuania with little leeway to increas e its healthcare spending dramatically over the...
View full press release